查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1453918

到 2030 年空胶囊（药物）市场预测：按类型、原产地、原材料、功能、应用、最终用户和地区进行的全球分析

Empty Capsules Market Forecasts to 2030 - Global Analysis By Type (Gelatin Capsules and Non-gelatin Capsules), Source (Porcine, Bovine and Natural), Raw Material, Functionality, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球空胶囊（药物）市场规模为 33 亿美元，预计预测期内复合年增长率为 8.6%，到 ​​2030 年将达到 58.8 亿美元。

空胶囊（药物）是一种通常由明胶或其他合适的聚合物製成的药物外壳。用作口服各种药物、补充品和草药的容器。这些胶囊有不同的尺寸、颜色和形状，以适应不同的配方和剂量要求。空胶囊（药物）提供了一种方便且无味的药物传递方法，特别是对于吞嚥锭剂有困难或不喜欢液体药物味道的人来说。

根据世界卫生组织（WHO）预测，60岁及以上的人口将从2000年的6.05亿增加到2050年的20亿。据 DealsOnHealth 称，到 2021 年，全球整体60 岁以上的女性中有 35% 每天都会使用美容产品。

製药业的成长

随着製药公司扩大研发以创新新药物和配方，对空胶囊（药物）的需求不断增加。这些胶囊由于其多功能性、易于吞嚥以及与各种製剂的相容性而成为各种药品的首选剂型。个人化医疗的不断增长趋势和利基药物的发展进一步推动了对空胶囊（药物）的需求，因为它们提供精确的剂量和易于自订。

品管与保证

空胶囊（药物）的品管和保证包括严格的措施，以确保胶囊符合监管标准和客户期望。这包括对原材料、製造流程和成品进行严格测试，以确保均匀性、稳定性和安全性。品管的重点是检测製造过程中的缺陷和偏差，而品质保证的重点是建立系统和通讯协定以防止问题发生。遵守良好生产规范 (GMP) 以及定期审核和检查以保持一致性和可靠性至关重要。

素食/纯素胶囊

素食胶囊通常由植物纤维素製成，适合因饮食、道德或宗教原因而避免使用动物源产品的人。同样，不含所有动物性成分的纯素胶囊吸引了越来越多的采用植物来源饮食的人。这一趋势促使製造商创新地提供传统明胶胶囊的植物来源替代品，开拓了一个利基市场，对道德和永续产品的需求不断增长。随着消费者对自己的选择更加了解，对素食和纯素胶囊的需求预计只会增加，这为我们提供的空胶囊（药品）领域的公司创造了利润丰厚的机会。

与替代输送系统的竞争

随着软胶囊、锭剂和软糖等各种替代给药方法的出现，对传统空胶囊（药物）的需求可能会减少。这些替代系统通常具有改善口味、易于食用和提高生物利用度等优点，对消费者俱有吸引力。此外，技术的进步使得能够满足特定需求和偏好的创新输送系统的开发成为可能。为了保持竞争力，空胶囊（药品）市场的製造商必须注重创新、品质和市场竞争，以使其产品脱颖而出并应对不断变化的消费者偏好。

COVID-19 的影响：

供应链和製造业的中断导致製造空胶囊（药物）所需的原材料短缺，导致生产延误和价格上涨。疫情食品对药品和营养补充的需求增加，进一步收紧了空胶囊（药物）的供应，而空胶囊（药品）对于封装药品和补充品至关重要。空胶囊（药品）市场的公司必须透过供应链多元化、探索替代采购选项以及投资提高产能来适应这些挑战。

明胶胶囊细分市场预计将在预测期内成为最大的细分市场

明胶胶囊源自动物胶原蛋白，由于生物分解性、易于消化以及与多种配方的相容性而广受欢迎。此外，它还为食品和营养补充提供出色的稳定性。对营养补充的需求不断增长，加上全球製药业的扩张，正在推动成长。

发炎药物领域预计在预测期内复合年增长率最高

由于关节炎、发炎性肠道疾病和气喘等发炎疾病的盛行率不断上升，空胶囊（药品）市场的发炎药物领域正在显着增长。随着患者寻求方便的剂型，空胶囊为药物封装提供了多功能且可客製化的解决方案。药物递送技术的进步使得能够开发出具有改善的生物有效性和标靶递送的新型製剂。此外，人口老化加上久坐的生活方式正在增加发炎疾病的盛行率，推动市场扩张。

占比最大的地区：

在北美，由于对药品和营养补充的需求不断增加，空胶囊（药物）市场正在经历显着增长。健康意识的增强和人口老化正在促进营养补充食品的扩张，并推动对空胶囊（药物）的需求。此外，FDA 等组织制定的监管核准和品质标准也增强了消费者的信心，进一步促进了市场成长。此外，该地区主要企业的存在和强大的分销网络使製造商可以轻鬆获得空胶囊（药物），从而促进市场扩张。

复合年增长率最高的地区：

由于製药和营养补充行业的成长、食品意识的增强以及可支配收入的增加，亚太地区的空胶囊（药物）市场正在显着成长。胶囊技术的进步和消费者对胶囊配方日益增长的偏好正在促进市场扩张。该地区人口基数大，老年人口不断增加，为空胶囊（药品）创造了巨大的市场，特别是在中国、印度和日本等国家。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球空胶囊（药物）市场：依类型

  • 明胶胶囊
    • 硬明胶胶囊
    • 软明胶胶囊
  • 非明胶胶囊

第六章全球空胶囊（药品）市场：依产地分类

  • 猪
  • 牛
  • 海洋
  • 自然的

第七章全球空胶囊（药品）市场：依原料分类

  • 羟丙基甲基纤维素（HPMC）
  • 淀粉原料
  • 普鲁兰胶

第八章全球空胶囊（药品）市场：依功能分类

  • 即时释放
  • 持续释放
  • 延迟释放

第九章全球空胶囊（药品）市场：依应用分类

  • 制酸剂和肠道调节剂
  • 营养补充食品
  • 心血管药物
  • 发炎药
  • 抗生素和抗菌药物
  • 咳嗽药和感冒药
  • 贫血预防药
  • 其他用途

第10章全球空胶囊（药品）市场：依最终用户分类

  • 製药和生物製药公司
  • 营养保健品公司
  • 其他最终用户

第十一章全球空胶囊（药品）市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司简介

  • ACG Worldwide
  • Bright Pharma Caps Inc
  • CapsCanada Corporation
  • Healthcaps India Ltd
  • Lonza Group
  • Medi-Caps Ltd
  • Nectar Lifesciences Ltd
  • Qingdao Yiqing Medicinal Capsules Co. Ltd
  • Qualicaps Inc
  • Roxlor LLC
  • Shanxi JC Biological Technology Co. Ltd
  • Snail Pharma Industry Co. Ltd
  • Suheung Capsule Co. Ltd
  • Sunil Healthcare Ltd
Product Code: SMRC25470

According to Stratistics MRC, the Global Empty Capsules Market is accounted for $3.30 billion in 2023 and is expected to reach $5.88 billion by 2030 growing at a CAGR of 8.6% during the forecast period. Empty capsules are pharmaceutical shells typically made from gelatin or other suitable polymers. They serve as containers for administering various medications, supplements, or herbal remedies orally. These capsules come in different sizes, colors, and shapes to accommodate diverse formulations and dosage requirements. Empty capsules provide a convenient and tasteless way to deliver medications, especially for individuals who have difficulty swallowing tablets or dislike the taste of liquid medications.

According to the World Health Organization (WHO), the population aged 60 years and above will increase from 605 million in 2000 to 2 billion in 2050. According to DealsOnHealth, in 2021, globally, 35% of women above 60 or older use beauty products every day.

Market Dynamics:

Driver:

Pharmaceutical industry growth

As pharmaceutical companies expand their research and development efforts to innovate new drugs and formulations, the demand for empty capsules rises. These capsules serve as a preferred dosage form for various drugs due to their versatility, ease of swallowing, and compatibility with different formulations. The growing trend towards personalized medicine and the development of niche drugs further fuel the demand for empty capsules, as they offer precise dosing and easy customization.

Restraint:

Quality control and assurance

Quality control and assurance in the empty capsule market involves stringent measures to ensure that capsules meet regulatory standards and customer expectations. This encompasses rigorous testing of raw materials, manufacturing processes, and finished products to guarantee uniformity, stability, and safety. Quality control focuses on detecting defects and deviations during production, while quality assurance involves implementing systems and protocols to prevent issues before they occur. Adherence to Good Manufacturing Practices (GMP) is paramount, alongside regular audits and inspections to maintain consistency and reliability.

Opportunity:

Vegetarian and vegan capsules

Vegetarian capsules, typically made from plant cellulose, cater to individuals who avoid animal-derived products for dietary, ethical, or religious reasons. Similarly, vegan capsules, which exclude all animal-derived ingredients, appeal to a growing segment of the population embracing plant-based diets. This trend has prompted manufacturers to innovate and offer plant-based alternatives to traditional gelatin capsules, tapping into a niche market with increasing demand for ethical and sustainable products. As consumers become more conscious of their choices, the demand for vegetarian and vegan capsules is expected to continue its upward trajectory, presenting a lucrative opportunity for businesses operating in the empty capsules sector.

Threat:

Competition from alternative delivery systems

With the emergence of various alternative delivery methods such as softgels, tablets, and gummies, the demand for traditional empty capsules may decline. These alternative systems often offer advantages such as improved taste, ease of consumption, and enhanced bioavailability, making them appealing to consumers. Additionally, advancements in technology have enabled the development of innovative delivery systems that cater to specific needs and preferences. To remain competitive, manufacturers in the empty capsule market must focus on innovation, quality, and customization to differentiate their products and adapt to changing consumer preferences.

Covid-19 Impact:

With the global disruption in supply chains and manufacturing, there has been a shortage of raw materials required for producing empty capsules, leading to production delays and increased prices. The increased demand for pharmaceuticals and nutraceuticals during the pandemic has further strained the supply of empty capsules, as they are essential for encapsulating drugs and supplements. Companies in the empty capsule market have had to adapt to these challenges by diversifying their supply chains, exploring alternative sourcing options, and investing in increased production capacity.

The gelatin capsules segment is expected to be the largest during the forecast period

The gelatin capsules segment has experienced robust growth within the empty capsule market as Gelatin capsules are derived from animal collagen, which have gained popularity due to their biodegradability, ease of digestion, and compatibility with a wide range of formulations. Moreover, they offer excellent stability for both pharmaceutical and nutraceutical products. The rising demand for dietary supplements, coupled with the expanding pharmaceutical industry globally, has fueled the growth.

The anti-inflammatory drugs segment is expected to have the highest CAGR during the forecast period

The anti-inflammatory drug segment within the empty capsule market has witnessed notable growth due to the rising prevalence of inflammatory disorders such as arthritis, inflammatory bowel disease, and asthma. As patients seek convenient dosage forms, empty capsules offer a versatile and customizable solution for drug encapsulation. Advancements in drug delivery technologies have enabled the development of novel formulations with improved bioavailability and targeted delivery. Moreover, the aging population, coupled with sedentary lifestyles, has contributed to the growing incidence of inflammatory conditions, fostering market expansion.

Region with largest share:

The North American region has experienced significant growth in the empty capsule market because of increased demand for pharmaceuticals and dietary supplements. Rising health consciousness and a growing aging population have contributed to the expansion of the nutritional supplement industry, driving the demand for empty capsules. Regulatory approvals and quality standards set by organizations such as the FDA have also instilled confidence in consumers, further boosting market growth. Additionally, the presence of key players and robust distribution networks within the region has facilitated market expansion, ensuring easy availability of empty capsules to manufacturers.

Region with highest CAGR:

The Asia-Pacific region has witnessed substantial growth in the empty capsule market due to increasing pharmaceutical and nutraceutical industries, coupled with rising healthcare awareness and disposable incomes. Advancements in capsule technology and growing consumer preference for capsule-based formulations contribute to market expansion. The region's large population base and expanding geriatric demographic create a substantial market for empty capsules, particularly in countries like China, India, and Japan.

Key players in the market

Some of the key players in Empty Capsules market include ACG Worldwide, Bright Pharma Caps Inc, CapsCanada Corporation, Healthcaps India Ltd, Lonza Group, Medi-Caps Ltd, Nectar Lifesciences Ltd, Qingdao Yiqing Medicinal Capsules Co. Ltd, Qualicaps Inc, Roxlor LLC, Shanxi JC Biological Technology Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Capsule Co. Ltd and Sunil Healthcare Ltd.

Key Developments:

In February 2024, Lonza has announced the launch of its new performance nutrition brand, Oceanix(TM) in the U.S.A and Canada. The unique phytoplankton ingredient is sustainably sourced from the ocean and meets rising demand for natural, non-GMO and vegan supplement products. Oceanix(TM) ingredient offers potential benefits for physical performance and an increased physiological response against oxidative stress to aid recovery in a small, concentrated dose.

In December 2023, Pharma and plant-based ingredient giant, Roquette, has confirmed its acquisition of Qualicaps from the Mitsubishu Chemical Group. This strategic investment offers Roquette the ability to expand the global footprint of its pharmaceutical business, as well as enrich its offerings of oral dosage solutions. Roquette's deep knowledge and expertise in the development of pharmaceutical excipients will be further enhanced by Qualicaps' expertise in capsules, as well as by their assets and infrastructure.

Types Covered:

  • Gelatin Capsules
  • Non-gelatin Capsules

Sources Covered:

  • Porcine
  • Bovine
  • Marine
  • Natural

Raw Materials Covered:

  • Hydroxy Propyl Methyl Cellulose (HPMC)
  • Starch Materials
  • Pullulan

Functionalities Covered:

  • Immediate Release
  • Sustained Release
  • Delayed Release

Applications Covered:

  • Antacid & Antiflatulent Preparations
  • Dietary Supplements
  • Cardiovascular Therapy Drugs
  • Anti-inflammatory Drugs
  • Antibiotic & Antibacterial Drugs
  • Cough & Cold Drugs
  • Antianemic Preparations
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biopharmaceutical Companies
  • Nutraceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Empty Capsules Market, By Type

  • 5.1 Introduction
  • 5.2 Gelatin Capsules
    • 5.2.1 Hard Gelatin Capsules
    • 5.2.2 Soft Gelatin Capsules
  • 5.3 Non-gelatin Capsules

6 Global Empty Capsules Market, By Source

  • 6.1 Introduction
  • 6.2 Porcine
  • 6.3 Bovine
  • 6.4 Marine
  • 6.5 Natural

7 Global Empty Capsules Market, By Raw Material

  • 7.1 Introduction
  • 7.2 Hydroxy Propyl Methyl Cellulose (HPMC)
  • 7.3 Starch Materials
  • 7.4 Pullulan

8 Global Empty Capsules Market, By Functionality

  • 8.1 Introduction
  • 8.2 Immediate Release
  • 8.3 Sustained Release
  • 8.4 Delayed Release

9 Global Empty Capsules Market, By Application

  • 9.1 Introduction
  • 9.2 Antacid & Antiflatulent Preparations
  • 9.3 Dietary Supplements
  • 9.4 Cardiovascular Therapy Drugs
  • 9.5 Anti-inflammatory Drugs
  • 9.6 Antibiotic & Antibacterial Drugs
  • 9.7 Cough & Cold Drugs
  • 9.8 Antianemic Preparations
  • 9.9 Other Applications

10 Global Empty Capsules Market, By End User

  • 10.1 Introduction
  • 10.2 Pharmaceutical & Biopharmaceutical Companies
  • 10.3 Nutraceutical Companies
  • 10.4 Other End Users

11 Global Empty Capsules Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 ACG Worldwide
  • 13.2 Bright Pharma Caps Inc
  • 13.3 CapsCanada Corporation
  • 13.4 Healthcaps India Ltd
  • 13.5 Lonza Group
  • 13.6 Medi-Caps Ltd
  • 13.7 Nectar Lifesciences Ltd
  • 13.8 Qingdao Yiqing Medicinal Capsules Co. Ltd
  • 13.9 Qualicaps Inc
  • 13.10 Roxlor LLC
  • 13.11 Shanxi JC Biological Technology Co. Ltd
  • 13.12 Snail Pharma Industry Co. Ltd
  • 13.13 Suheung Capsule Co. Ltd
  • 13.14 Sunil Healthcare Ltd

List of Tables

  • Table 1 Global Empty Capsules Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Empty Capsules Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Empty Capsules Market Outlook, By Gelatin Capsules (2021-2030) ($MN)
  • Table 4 Global Empty Capsules Market Outlook, By Hard Gelatin Capsules (2021-2030) ($MN)
  • Table 5 Global Empty Capsules Market Outlook, By Soft Gelatin Capsules (2021-2030) ($MN)
  • Table 6 Global Empty Capsules Market Outlook, By Non-gelatin Capsules (2021-2030) ($MN)
  • Table 7 Global Empty Capsules Market Outlook, By Source (2021-2030) ($MN)
  • Table 8 Global Empty Capsules Market Outlook, By Porcine (2021-2030) ($MN)
  • Table 9 Global Empty Capsules Market Outlook, By Bovine (2021-2030) ($MN)
  • Table 10 Global Empty Capsules Market Outlook, By Marine (2021-2030) ($MN)
  • Table 11 Global Empty Capsules Market Outlook, By Natural (2021-2030) ($MN)
  • Table 12 Global Empty Capsules Market Outlook, By Raw Material (2021-2030) ($MN)
  • Table 13 Global Empty Capsules Market Outlook, By Hydroxy Propyl Methyl Cellulose (HPMC) (2021-2030) ($MN)
  • Table 14 Global Empty Capsules Market Outlook, By Starch Materials (2021-2030) ($MN)
  • Table 15 Global Empty Capsules Market Outlook, By Pullulan (2021-2030) ($MN)
  • Table 16 Global Empty Capsules Market Outlook, By Functionality (2021-2030) ($MN)
  • Table 17 Global Empty Capsules Market Outlook, By Immediate Release (2021-2030) ($MN)
  • Table 18 Global Empty Capsules Market Outlook, By Sustained Release (2021-2030) ($MN)
  • Table 19 Global Empty Capsules Market Outlook, By Delayed Release (2021-2030) ($MN)
  • Table 20 Global Empty Capsules Market Outlook, By Application (2021-2030) ($MN)
  • Table 21 Global Empty Capsules Market Outlook, By Antacid & Antiflatulent Preparations (2021-2030) ($MN)
  • Table 22 Global Empty Capsules Market Outlook, By Dietary Supplements (2021-2030) ($MN)
  • Table 23 Global Empty Capsules Market Outlook, By Cardiovascular Therapy Drugs (2021-2030) ($MN)
  • Table 24 Global Empty Capsules Market Outlook, By Anti-inflammatory Drugs (2021-2030) ($MN)
  • Table 25 Global Empty Capsules Market Outlook, By Antibiotic & Antibacterial Drugs (2021-2030) ($MN)
  • Table 26 Global Empty Capsules Market Outlook, By Cough & Cold Drugs (2021-2030) ($MN)
  • Table 27 Global Empty Capsules Market Outlook, By Antianemic Preparations (2021-2030) ($MN)
  • Table 28 Global Empty Capsules Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Global Empty Capsules Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Empty Capsules Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2021-2030) ($MN)
  • Table 31 Global Empty Capsules Market Outlook, By Nutraceutical Companies (2021-2030) ($MN)
  • Table 32 Global Empty Capsules Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.